Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing
Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
Who this might be right for
HIV Infections
ViiV Healthcare 171